214 related articles for article (PubMed ID: 20153011)
1. Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F.
Khatua AK; Taylor HE; Hildreth JE; Popik W
Virology; 2010 Apr; 400(1):68-75. PubMed ID: 20153011
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of Alu retrotransposition by APOBEC3G.
Hulme AE; Bogerd HP; Cullen BR; Moran JV
Gene; 2007 Apr; 390(1-2):199-205. PubMed ID: 17079095
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins.
Gallois-Montbrun S; Holmes RK; Swanson CM; Fernández-Ocaña M; Byers HL; Ward MA; Malim MH
J Virol; 2008 Jun; 82(11):5636-42. PubMed ID: 18367521
[TBL] [Abstract][Full Text] [Related]
4. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.
Chiu YL; Witkowska HE; Hall SC; Santiago M; Soros VB; Esnault C; Heidmann T; Greene WC
Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15588-93. PubMed ID: 17030807
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
6. Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.
Russell RA; Smith J; Barr R; Bhattacharyya D; Pathak VK
J Virol; 2009 Feb; 83(4):1992-2003. PubMed ID: 19036809
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
Han Y; Wang X; Dang Y; Zheng YH
PLoS Pathog; 2008 Jul; 4(7):e1000095. PubMed ID: 18604271
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3G oligomerization is associated with the inhibition of both Alu and LINE-1 retrotransposition.
Koyama T; Arias JF; Iwabu Y; Yokoyama M; Fujita H; Sato H; Tokunaga K
PLoS One; 2013; 8(12):e84228. PubMed ID: 24367644
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
10. Promiscuous RNA binding ensures effective encapsidation of APOBEC3 proteins by HIV-1.
Apolonia L; Schulz R; Curk T; Rocha P; Swanson CM; Schaller T; Ule J; Malim MH
PLoS Pathog; 2015 Jan; 11(1):e1004609. PubMed ID: 25590131
[TBL] [Abstract][Full Text] [Related]
11. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
12. Stably expressed APOBEC3F has negligible antiviral activity.
Miyagi E; Brown CR; Opi S; Khan M; Goila-Gaur R; Kao S; Walker RC; Hirsch V; Strebel K
J Virol; 2010 Nov; 84(21):11067-75. PubMed ID: 20702622
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.
Mbisa JL; Bu W; Pathak VK
J Virol; 2010 May; 84(10):5250-9. PubMed ID: 20219927
[TBL] [Abstract][Full Text] [Related]
14. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.
Koning FA; Newman EN; Kim EY; Kunstman KJ; Wolinsky SM; Malim MH
J Virol; 2009 Sep; 83(18):9474-85. PubMed ID: 19587057
[TBL] [Abstract][Full Text] [Related]
15. Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1.
Tan L; Sarkis PT; Wang T; Tian C; Yu XF
FASEB J; 2009 Jan; 23(1):279-87. PubMed ID: 18827027
[TBL] [Abstract][Full Text] [Related]
16. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
[TBL] [Abstract][Full Text] [Related]
17. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA; Pathak VK
J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
[TBL] [Abstract][Full Text] [Related]
18. Characterization of APOBEC3G binding to 7SL RNA.
Bach D; Peddi S; Mangeat B; Lakkaraju A; Strub K; Trono D
Retrovirology; 2008 Jul; 5():54. PubMed ID: 18597676
[TBL] [Abstract][Full Text] [Related]
19. Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.
Song C; Sutton L; Johnson ME; D'Aquila RT; Donahue JP
J Biol Chem; 2012 May; 287(20):16965-74. PubMed ID: 22451677
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism.
Stenglein MD; Harris RS
J Biol Chem; 2006 Jun; 281(25):16837-16841. PubMed ID: 16648136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
